XL Mont 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic rhinitis and chronic asthma. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic conditions. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors in the airway, mitigating bronchoconstriction, inflammation, and mucus production, which are key contributors to asthma pathophysiology. The synergistic action of these agents provides comprehensive relief from both upper and lower airway allergic manifestations. XL Mont is typically administered once daily, preferably in the evening, to optimize therapeutic outcomes and improve patient compliance. It is suitable for adult and pediatric patients above a specified age, as per clinical guidelines. Common adverse effects may include headache, fatigue, and gastrointestinal discomfort, though the combination is generally well tolerated. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in individuals with known hypersensitivity to either component. XL Mont 5mg/10mg Tablet offers an effective dual approach for controlling allergic symptoms and preventing asthma exacerbations, enhancing overall respiratory health and quality of life.